Euroapi (XPAR:EAPI) Repurchase of Stock: €-0.5 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPAR:EAPI Euroapi SA XPAR:EAPI
49 GF Score
Price €0.78
GF Value €2.51
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Euroapi Repurchase of Stock?

Euroapi XPAR:EAPI -8.13% 49 Repurchase of Stock is €-0.5 Mil as of Jun. 2026. GuruFocus rates XPAR:EAPI with a GF Score™ of 49/100 and a GF Value™ of €2.51 (Possible Value Trap). The stock has 6 warning signs investors should review.

Euroapi's Repurchase of Stock for the six months ended in Jun. 2026 was €-0.5 Mil.

Euroapi's Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2026 was €-0.5 Mil.

Euroapi Repurchase of Stock Related Terms

Euroapi Repurchase of Stock Historical Data

* Premium members only.

The historical data trend for Euroapi's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Euroapi Repurchase of Stock Chart

Euroapi Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Repurchase of Stock
Get a 7-Day Free Trial 0.00 -1.30 -0.60 -0.10 0.00

Euroapi Semi-Annual Data
Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only 0.00 -0.10 0.00 0.00 -0.50
XPAR:EAPI
49GF Score
Euroapi SA XPAR:EAPI
Repurchase of Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Euroapi Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Repurchase of Stock →
What does a Repurchase of Stock of €-0.5 Mil mean?
Euroapi (XPAR:EAPI) has a Repurchase of Stock of €-0.5 Mil as of Jun. 2026. Repurchase of Stock is the total amount of company share repurchases. View historical data for Euroapi and its competitors.
Is Euroapi's Repurchase of Stock too high?
Euroapi's current Repurchase of Stock is €-0.5 Mil. Overall, Euroapi has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Euroapi's Repurchase of Stock compare to ZTS and UTHR?
Euroapi's Repurchase of Stock of €-0.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Repurchase of Stock for a Drug Manufacturers company?
A good Repurchase of Stock depends on the Drug Manufacturers industry context. However, Repurchase of Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Repurchase of Stock mean?
A high Repurchase of Stock can signal that a stock is expensive relative to its fundamentals. Repurchase of Stock is the total amount of company share repurchases. View historical data for Euroapi and its competitors. Euroapi's current Repurchase of Stock is €-0.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Euroapi stock overvalued right now?
Based on GuruFocus' analysis, Euroapi (XPAR:EAPI) is currently considered Possible Value Trap. The stock's GF Value™ is €2.51, compared to a current price of €0.78 — trading 68.8% below its estimated fair value. The current Repurchase of Stock is €-0.5 Mil. Euroapi's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Repurchase of Stock calculated?
Repurchase of Stock is calculated from a company's financial statements. For Euroapi (XPAR:EAPI), the current Repurchase of Stock is €-0.5 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Euroapi (XPAR:EAPI) Overvalued in 2026?

Based on GuruFocus' analysis, Euroapi stock appears to be undervalued. The current stock price of €0.78 is trading 68.8% below its estimated GF Value™ of €2.51. GuruFocus considers Euroapi to be Possible Value Trap.

Key valuation signals for XPAR:EAPI:

  • Repurchase of Stock: €-0.5 Mil
  • GF Value™: €2.51 vs. price of €0.78 (68.8% below fair value)
  • GF Score™: 49/100 with 6 warning signs

No single metric tells the full story. See the XPAR:EAPI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Euroapi Business Description

Other Exchanges EAPIF:USA0EAP:UK940:Germany
Address 32 rue Alexandre Duma, Paris, FRA, 75011
Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics. The company offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates, analgesics, and others. It also offers Contract Development Manufacturing Organization (CDMO) services to its customers.
49GF Score

Get the complete analysis for XPAR:EAPI

Repurchase of Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.78
Price
€2.51
GF Value